Lorazepam: Difference between revisions
>Ayylmaonade m Analysis suppression was listed twice under cognitive effects. |
>David Hedlund |
||
Line 103: | Line 103: | ||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Anxiolytics]] | |||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Benzodiazepine]] | [[Category:Benzodiazepine]] |